Dubai: The 2023 edition of the PrecisionMed Exhibition & Summit (PMES), the Middle East’s leading event dedicated to the advancement of precision medicine in the region, is set to take place on May 23–24 at the Dubai World Trade Centre.
Bringing together key figures in the field of precision medicine, PMES 2023 will offer a unique platform for knowledge sharing and collaboration by reviewing the practical application of precision medicine and encouraging clinical adoption. Attendees can expect engaging discussions, insightful presentations, and interactive exhibits showcasing the latest breakthroughs and technologies in precision medicine.
PMES 2023 is generously supported by the UAE’s Ministry of Industry and Advanced Technology (MoIAT), Ministry of Health and Prevention (MoHAP), Department of Health (DoH) Abu Dhabi, and the Dubai Health Authority (DHA).
Mr. David Stradling, Managing Director of PMES, commented that “in 2022, the global market was valued at about $73.5 billion by 2030, we will exceed $175 billion. Developed markets are being serviced by companies in this space, and they are now turning to the significant opportunities offered by the Middle East and North Africa, where genetic screening is in growing demand.”
Ms. Aisha Al Mulla, Director of Friends of Cancer Patients, added that “the endorsement of the integration of personalised and precision medicine can improve diagnostics, drug therapy, and health outcomes by tailoring the treatment plan to the needs of each cancer patient.”
The PMES 2023 summit will further feature informed presentations and debate, with conference speakers exploring the real-world application of genetics and genome-based systems and the movement towards customised healthcare to tackle disease and benefit patients.
The event will also showcase a host of healthcare providers, companies, and other organisations demonstrating their latest cutting-edge technology in precision medicine, serving as a catalyst to drive progress in personalised healthcare solutions.